$ --

Doxepin Hydrochloride Pricing fluctuated throughout the second quarter, owing to the volatile feedstock prices and emerging demand outlook from the pharmaceutical sector. As its mainly utilized in treating depression and anxiety, its demand remains healthy worldwide. Furthermore, Doxepin is tricyclic antidepressant, approved by FDA in 1969 to treat the major depressive disorder. Doxepin was primarily approved to treat depression; however, it requires thinly chloride and dimethyl methylamine in its production process. Therefore, changing feedstock cost further contributes to the mixed market for Doxepin HCL in the regional market. At the same time, port congestion and altering freight cost aided the shifting market trend.

For more information

E-Mail:- sales@chemanalyst.com

websites:-  https://www.chemanalyst.com/Pricing-data/doxepin-hcl-1420

Contact No:- +13322586602